Vancouver, British Columbia–(Newsfile Corp. – April 21, 2022) – MYND Life Sciences Inc. (CSE: MYND) (OTCQB: MYNDF)(“MYND” or the “Company“), is pleased to announce that it plans to undertake a non-brokered private placement offering (the “Offering“) of common shares in share capital of the Company (“Shares“) to raise gross proceeds of a minimum of $3,000,000 up to $3,500,000, or such other amounts…


Previous articlePsychedelic Research Bulletin: March 2022
Next articlePT313 – Christine Calvert, LCDC – Holotropic Breathwork, Ethics, and Dying To Ourselves